These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 19690758)

  • 21. Significance of intramammary lymph nodes in the staging of breast cancer: correlation with tumor characteristics and outcome.
    Nassar A; Cohen C; Cotsonis G; Carlson G
    Breast J; 2008; 14(2):147-52. PubMed ID: 18248563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancer.
    Ferrucci PF; Rabascio C; Mazzetta C; Cocorocchio E; Agazzi A; Vanazzi A; Cinieri S; Peccatori FA; Paolucci M; Bertolini F; Martinelli G
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6039-46. PubMed ID: 15447988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of FHIT expression in breast cancer is correlated with poor prognostic markers.
    Arun B; Kilic G; Yen C; Foster B; Yardley DA; Gaynor R; Ashfaq R
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1681-5. PubMed ID: 16030101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up study of a prospective multicenter sentinel node trial: molecular detection of breast cancer sentinel node metastases.
    Verbanac KM; Min CJ; Mannie AE; Lu J; O'Brien KF; Rosman M; Tafra L;
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():368-77. PubMed ID: 20853060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
    Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
    Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas.
    Ciampa A; Fanger G; Khan A; Rock KL; Xu B
    Cancer; 2004 Dec; 102(6):368-72. PubMed ID: 15558786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of three mRNA markers for the detection of lymph node metastases.
    Berger J; Mueller-Holzner E; Fiegl H; Marth C; Daxenbichler G
    Anticancer Res; 2006; 26(5B):3855-60. PubMed ID: 17094413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiogenesis as determined by computerised image analysis and the risk of early relapse in women with invasive ductal breast carcinoma.
    Olewniczak S; Chosia M; Kołodziej B; Kwas A; Kram A; Domagała W
    Pol J Pathol; 2003; 54(1):53-9. PubMed ID: 12817881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53].
    Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD1a down-regulation in primary invasive ductal breast carcinoma may predict regional lymph node invasion and patient outcome.
    La Rocca G; Anzalone R; Corrao S; Magno F; Rappa F; Marasà S; Czarnecka AM; Marasà L; Sergi C; Zummo G; Cappello F
    Histopathology; 2008 Jan; 52(2):203-12. PubMed ID: 18184269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of RT-PCR detection of human mammaglobin for the diagnosis of breast cancer derived pleural effusions.
    Roncella S; Ferro P; Bacigalupo B; Dessanti P; Pronzato P; Franceschini MC; Pratticò L; Carletti AM; Canessa PA; Fontana V; Fais F; Pistillo MP; Fedeli F
    Diagn Mol Pathol; 2008 Mar; 17(1):28-33. PubMed ID: 18303409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. M34 actin regulatory protein is a sensitive diagnostic marker for early- and late-stage mammary carcinomas.
    Soriano Z; Pardee JD
    Clin Cancer Res; 2004 Jul; 10(13):4437-43. PubMed ID: 15240534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of chemotherapy on status of estrogen receptors in primary tumors and lymph node metastases of human ductal breast cancer.
    Koda M; Lenczewski A; Sulkowska M; Kanczuga-Koda L; Wincewicz A; Tomaszewski J; Sulkowski S
    Oncol Rep; 2007 Feb; 17(2):385-91. PubMed ID: 17203178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer.
    Reinholz MM; Nibbe A; Jonart LM; Kitzmann K; Suman VJ; Ingle JN; Houghton R; Zehentner B; Roche PC; Lingle WL
    Clin Cancer Res; 2005 May; 11(10):3722-32. PubMed ID: 15897569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases.
    Braun M; Flucke U; Debald M; Walgenbach-Bruenagel G; Walgenbach KJ; Höller T; Pölcher M; Wolfgarten M; Sauerwald A; Keyver-Paik M; Kühr M; Büttner R; Kuhn W
    Breast Cancer Res Treat; 2008 Dec; 112(3):503-11. PubMed ID: 18165897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sentinel lymph node molecular pathology in breast carcinoma.
    Denninghoff V; Allende D; Paesani F; Garcia A; Avagnina A; Perazzo F; Abalo E; Crimi G; Elsner B
    Diagn Mol Pathol; 2008 Dec; 17(4):214-9. PubMed ID: 18382355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.
    Ntoulia M; Stathopoulou A; Ignatiadis M; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
    Clin Biochem; 2006 Sep; 39(9):879-87. PubMed ID: 16925986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis.
    Shen D; Nooraie F; Elshimali Y; Lonsberry V; He J; Bose S; Chia D; Seligson D; Chang HR; Goodglick L
    Hum Pathol; 2006 Dec; 37(12):1583-91. PubMed ID: 16949910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omics-based profiling of carcinoma of the breast and matched regional lymph node metastasis.
    Li J; Gromov P; Gromova I; Moreira JM; Timmermans-Wielenga V; Rank F; Wang K; Li S; Li H; Wiuf C; Yang H; Zhang X; Bolund L; Celis JE
    Proteomics; 2008 Dec; 8(23-24):5038-52. PubMed ID: 19003862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HYOU1/Orp150 expression in breast cancer.
    Stojadinovic A; Hooke JA; Shriver CD; Nissan A; Kovatich AJ; Kao TC; Ponniah S; Peoples GE; Moroni M
    Med Sci Monit; 2007 Nov; 13(11):BR231-239. PubMed ID: 17968289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.